A polyisoprenyl phenolic compound, and a preparation method and application thereof

By isolating and purifying polyisoprene phenolic compounds from Boletus styracifolius, the problems of significant side effects and drug resistance in existing liver cancer treatments have been solved, providing a highly efficient and safe anti-liver cancer drug solution.

CN117903101BActive Publication Date: 2025-12-09HEBEI NORMAL UNIV
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202410054257.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-01-15
Publication Date
2025-12-09
Estimated Expiration
2044-01-15

Smart Images

  • Figure CN117903101B_ABST
    Figure CN117903101B_ABST
Patent Text Reader

Abstract

The application provides a polyisoprenyl phenolic compound and a preparation method and application thereof. The application takes dry fruit bodies of Leucangium carthusianum as raw materials, extracts the dry fruit bodies through ethanol, extracts a petroleum ether phase through petroleum ether, and then coarsely separates the petroleum ether phase through petroleum ether-ethyl acetate solutions with different proportions, and then elutes and separates the petroleum ether phase through dichloromethane-methanol with a specific proportion, so as to obtain a polyisoprenyl phenolic compound with a novel structure. The polyisoprenyl phenolic compound provided by the application has a significant in-vitro inhibitory activity on HepG2 cell proliferation, and the inhibitory activity on liver cancer cells is obviously better than that of cisplatin, and the polyisoprenyl phenolic compound can be used for preparing medicines for treating and preventing liver cancer. Meanwhile, the raw material of the compound is rich in source, low in price, and simple in preparation process, and is convenient for industrial application, so that the discovery of the compound is expected to provide a promising treatment scheme for liver cancer patients, and has great significance for breaking through a bottleneck in liver cancer treatment.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Boletus edulis polysaccharide SGP2-1 with immunomodulatory activity as well as preparation method and application of boletus edulis polysaccharide SGP2-1

    CN113817076A

  • Extraction method for polyprenols

    WO2005086603A2